CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 240 filers reported holding CONMED CORP in Q1 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $41,290,179 | -15.6% | 595,668 | -2.5% | 0.02% | -13.8% |
Q1 2024 | $48,946,842 | -25.5% | 611,224 | +1.8% | 0.03% | -31.0% |
Q4 2023 | $65,742,626 | +6.3% | 600,334 | -2.1% | 0.04% | -4.5% |
Q3 2023 | $61,855,706 | -28.4% | 613,355 | -3.6% | 0.04% | -25.4% |
Q2 2023 | $86,436,968 | +4.4% | 636,104 | -20.2% | 0.06% | 0.0% |
Q1 2023 | $82,790,877 | +30.8% | 797,151 | +11.7% | 0.06% | +22.9% |
Q4 2022 | $63,282,490 | +9.2% | 713,927 | -1.2% | 0.05% | +4.3% |
Q3 2022 | $57,939,000 | -14.8% | 722,654 | +1.8% | 0.05% | -8.0% |
Q2 2022 | $68,009,000 | -37.3% | 710,197 | -2.7% | 0.05% | -26.5% |
Q1 2022 | $108,397,000 | -0.7% | 729,700 | -6.1% | 0.07% | +4.6% |
Q4 2021 | $109,121,000 | +4.8% | 776,989 | -2.4% | 0.06% | -4.4% |
Q3 2021 | $104,114,000 | -11.2% | 795,807 | -6.7% | 0.07% | -10.5% |
Q2 2021 | $117,248,000 | +14.2% | 853,147 | +8.6% | 0.08% | +5.6% |
Q1 2021 | $102,628,000 | -0.1% | 785,881 | -14.3% | 0.07% | -5.3% |
Q4 2020 | $102,697,000 | +28.4% | 916,933 | -9.8% | 0.08% | +13.4% |
Q3 2020 | $79,967,000 | +8.4% | 1,016,490 | -0.8% | 0.07% | +3.1% |
Q2 2020 | $73,792,000 | +37.5% | 1,025,049 | +9.4% | 0.06% | +10.2% |
Q1 2020 | $53,663,000 | -32.4% | 937,097 | +32.0% | 0.06% | -10.6% |
Q4 2019 | $79,381,000 | +15.8% | 709,837 | -0.4% | 0.07% | +10.0% |
Q3 2019 | $68,556,000 | +14.4% | 713,008 | +1.8% | 0.06% | +11.1% |
Q2 2019 | $59,929,000 | +31.4% | 700,363 | +27.7% | 0.05% | +28.6% |
Q1 2019 | $45,611,000 | +214.2% | 548,342 | +142.5% | 0.04% | +180.0% |
Q4 2018 | $14,515,000 | -18.3% | 226,093 | +0.9% | 0.02% | -6.2% |
Q3 2018 | $17,758,000 | +15.9% | 224,153 | +7.1% | 0.02% | +14.3% |
Q2 2018 | $15,318,000 | +18.7% | 209,263 | +2.7% | 0.01% | +16.7% |
Q1 2018 | $12,908,000 | +28.0% | 203,810 | +3.0% | 0.01% | +33.3% |
Q4 2017 | $10,088,000 | -4.5% | 197,919 | -1.7% | 0.01% | -10.0% |
Q3 2017 | $10,561,000 | +2.1% | 201,264 | -0.9% | 0.01% | 0.0% |
Q2 2017 | $10,347,000 | +20.2% | 203,120 | +4.8% | 0.01% | 0.0% |
Q1 2017 | $8,610,000 | +4.1% | 193,880 | +3.6% | 0.01% | 0.0% |
Q4 2016 | $8,268,000 | +13.9% | 187,176 | +3.3% | 0.01% | 0.0% |
Q3 2016 | $7,257,000 | -16.3% | 181,165 | -0.2% | 0.01% | -16.7% |
Q2 2016 | $8,668,000 | +16.9% | 181,610 | +2.8% | 0.01% | +9.1% |
Q1 2016 | $7,412,000 | -4.1% | 176,718 | +0.8% | 0.01% | 0.0% |
Q4 2015 | $7,725,000 | -0.3% | 175,360 | +8.0% | 0.01% | -8.3% |
Q3 2015 | $7,749,000 | -23.1% | 162,307 | -6.1% | 0.01% | -20.0% |
Q2 2015 | $10,071,000 | +13.5% | 172,835 | -1.7% | 0.02% | +15.4% |
Q1 2015 | $8,875,000 | +15.3% | 175,761 | +2.7% | 0.01% | +8.3% |
Q4 2014 | $7,697,000 | +22.4% | 171,182 | +0.3% | 0.01% | +9.1% |
Q3 2014 | $6,286,000 | -17.1% | 170,626 | -0.7% | 0.01% | -15.4% |
Q2 2014 | $7,584,000 | +1.3% | 171,795 | -0.3% | 0.01% | 0.0% |
Q1 2014 | $7,487,000 | +4.4% | 172,318 | +2.1% | 0.01% | 0.0% |
Q4 2013 | $7,170,000 | +33.4% | 168,695 | +6.7% | 0.01% | +18.2% |
Q3 2013 | $5,373,000 | +11.3% | 158,090 | +2.3% | 0.01% | 0.0% |
Q2 2013 | $4,829,000 | – | 154,575 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |